Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$552,438
+$19,341 QoQ
Shares Held
3,525
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#841
of 1,603 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CoreFirst Bank & Trust holds $7,786,859 across 11 Drug Manufacturers - General names. NVS ranks #6 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
11,471 | $2,913,289 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,877 | $1,140,694 | |
| 3 | AMGN |
Amgen Inc
|
2,643 | $957,082 | |
| 4 | ABBV |
AbbVie Inc.
|
3,751 | $943,900 | |
| 5 | LLY |
ELI LILLY & Co
|
515 | $617,706 | |
| 6 | NVS |
Novartis AG
This page
|
3,525 | $552,438 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,427 | $255,083 | |
| 8 | NVO |
Novo Nordisk A S
|
4,723 | $226,420 |
All Filings in NVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $552,438 | 3,525 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $533,097 | 3,490 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $475,651 | 3,450 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $443,710 | 3,460 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $415,064 | 3,430 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $335,554 | 3,010 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $224,786 | 2,310 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $251,893 | 2,190 | Shares | Sole | 2025-02-11 | |
| 2024-06-30 | $234,105 | 2,199 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $212,708 | 2,199 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $234,552 | 2,323 | Shares | Sole | 2024-03-18 | |
| 2023-09-30 | $236,620 | 2,323 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $235,119 | 2,330 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $214,360 | 2,330 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $211,377 | 2,330 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $177,102 | 2,330 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $196,954 | 2,330 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $195,682 | 2,230 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $195,057 | 2,230 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $223,259 | 2,730 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $194,797 | 2,135 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $182,499 | 2,135 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $201,607 | 2,135 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||